By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish, with the main concern being the significant potential fines and restrictions from ongoing U.S. anti-money laundering investigations, which could offset TD's operational momentum and capital markets strength. The single biggest risk flagged is the immediate and quantifiable AML settlement risk, while the key opportunity is the potential for multiple expansion and capital markets strength to drive targets, despite questions about earnings quality and sustainability.
Risk: AML settlement risk
Opportunity: multiple expansion and capital markets strength
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The Toronto-Dominion Bank (NYSE:TD) is one of the top cheap stocks with Strong Buy ratings on Wall Street. RBC Capital lifted the price target on The Toronto-Dominion Bank (NYSE:TD) to C$156 from C$138 on June 1 and maintained an Outperform rating on the shares.
The company also received a rating update from Jefferies on May 28, with the firm raising the price target on The Toronto-Dominion Bank (NYSE:TD) to C$151 from C$142 and maintaining a Hold rating on the shares. The firm stated that fiscal Q2 exhibited the company’s breadth, with solid contributions across the board, adding that further better-than-forecast capital markets results highlight that The Toronto-Dominion Bank (NYSE:TD) has enhanced that platform. It also noted that credit performance in the U.S. was compelling and management is confident that lending in the region should begin to pick up.
For reference, in its financial results for the quarter ended April 30, 2026, The Toronto-Dominion Bank (NYSE:TD) announced that reported diluted earnings per share were $2.43, compared with $6.27 in the prior year period, while adjusted diluted earnings per share were $2.38, compared to $1.97 in fiscal Q2 2025.
The Toronto-Dominion Bank (NYSE:TD) provides financial products and services. Its operations are divided into the following segments: Canadian Personal and Commercial Banking, U.S. Retail, Wealth Management and Insurance, Wholesale Banking, and Corporate segment.
While we acknowledge the potential of TD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Upgrades may reflect optimism about multiple expansion and capital-markets rebound rather than durable earnings growth, given a weak GAAP base and sensitivity to rate and credit cycles."
TD's diversified mix across Canadian P&C, U.S. Retail, Wealth, and Wholesale gives optionality, and RBC/Jefferies upgrades suggest optimism on cross-segment strength. Yet Q2 FY2026 shows a stark GAAP earnings drop to $2.43 per share from $6.27 a year earlier, with adjusted EPS of $2.38 (up from $1.97). That weak base questions earnings quality and leaves results vulnerable to rate paths and U.S. credit cycles. The targets may rely more on multiple expansion and capital-markets strength than sustainable profitability. The article’s promotional tone (AI stock plug) adds noise and distracts from real drivers: forward guidance on margins, loan growth, and credit quality remains missing.
The strongest counter: the huge year-ago GAAP base makes 2026 look fragile on the surface; without clear, durable improvements in net interest income and credit costs, upgrades could be sentiment-driven rather than fundamentals.
"The market is underestimating the long-term earnings impact and growth constraints stemming from TD's ongoing U.S. anti-money laundering regulatory investigations."
RBC’s price target hike to C$156 reflects optimism regarding TD’s capital markets expansion, but the market is ignoring the severe regulatory overhang. While adjusted EPS growth to $2.38 shows operational resilience, the bank remains mired in ongoing U.S. anti-money laundering (AML) investigations. These probes could result in significant fines and, more crucially, restrictions on future U.S. expansion or balance sheet growth. Investors are pricing in a 'business as usual' recovery, yet the structural risk of a multi-billion dollar settlement and potential regulatory consent orders suggests the current valuation fails to fully discount the cost of compliance remediation and potential earnings volatility in the U.S. retail segment.
If the AML settlement is finalized at the lower end of analyst estimates, the removal of this 'regulatory cloud' could trigger a massive valuation re-rating as the market refocuses on TD's strong Canadian franchise and capital markets momentum.
"TD's adjusted earnings are improving, but the 62% reported EPS decline year-over-year demands explanation before treating this as a clean bullish setup."
RBC and Jefferies both raising PTs on TD suggests genuine operational momentum—Q2 adjusted EPS of $2.38 vs. $1.97 YoY is a 21% beat, and capital markets strength plus U.S. credit performance are real tailwinds. However, the reported EPS collapse ($2.43 vs. $6.27) signals massive one-time charges or accounting adjustments the article doesn't explain. RBC's C$156 PT implies ~13% upside from current levels, modest for a 'Strong Buy.' The article's breathless tone masks that Jefferies kept a Hold rating despite raising its PT—a yellow flag on conviction.
If that reported EPS miss reflects structural credit deterioration being masked by adjusted metrics, or if U.S. lending 'pickup' is management optimism rather than confirmed demand, the adjusted narrative collapses and multiple compression follows.
"TD's sharp reported EPS decline introduces material uncertainty that analyst price target increases alone do not resolve."
Analyst upgrades from RBC to C$156 and Jefferies to C$151 reflect TD's diversified segments and stronger U.S. credit trends after Q2 results. Yet the reported EPS plunge to $2.43 from $6.27 signals possible large provisions or writedowns omitted from the bullish narrative, while adjusted EPS rose only modestly to $2.38. The article's quick pivot to AI stocks further implies limited conviction in TD's upside. Interest-rate sensitivity and Canadian housing exposure remain unaddressed risks that could offset capital markets gains if lending recovery stalls.
The reported EPS drop may reflect a one-time item unrelated to core operations, allowing the adjusted growth and PT hikes to accurately capture improving fundamentals.
"AML/regulatory risk and U.S. constraints could cap TD's upside even as adjusted EPS improves; upgrades may be priced on sentiment rather than durable earnings."
Gemini makes a strong case on the AML risk, but the piece underplays the size and probability of a settlement, and how that could mute the upside even if adjusted EPS advances. The confluence of U.S. regulatory costs, potential consent orders, and limits on U.S. balance-sheet growth could reprice TD's EBT/ROE trajectory, offsetting Canadian franchise strength and capital-markets momentum. Until settlement path and NII sensitivities are quantified, upgrades look sentiment-driven.
"TD's domestic exposure to Canadian residential real estate presents a greater systemic risk to earnings than the U.S. regulatory overhang."
Claude is right to flag the Jefferies 'Hold' rating as a yellow flag, but the panel is collectively ignoring the Canadian housing market's role in this. TD’s mortgage book is the real ticking time bomb, not just the U.S. AML issues. If Canadian unemployment ticks higher, the provision for credit losses (PCL) will blow through these 'adjusted' earnings metrics. The market is pricing in a U.S. recovery while ignoring domestic systemic risk in Canada’s residential real estate.
"AML settlement is a near-term, quantifiable earnings headwind; Canadian housing risk is real but temporally distinct and currently underpriced by both bulls and bears."
Gemini's Canadian housing bomb is real, but the sequencing matters. TD's mortgage PCL typically lags unemployment by 2–3 quarters; current unemployment is still benign. The AML settlement risk is *immediate* and quantifiable (likely $2–4B based on peer precedent), while housing stress is conditional on a recession. We're conflating timeline. If settlement lands in H2 2026, it's a 2026 earnings hit. Housing deterioration is 2027–2028. The upgrades price neither adequately.
"AML consent orders could restrict U.S. diversification precisely when Canadian housing stress materializes, compounding rather than sequencing the risks."
Claude's clean split between 2026 AML and 2027-28 housing timelines ignores how consent orders could cap U.S. balance-sheet growth exactly when Canadian mortgage PCLs rise. TD would then lose the cross-segment offset the RBC PT assumes, turning two sequential risks into simultaneous earnings pressure. Rate sensitivity on the mortgage book amplifies this overlap rather than sequencing it away.
The panel consensus is bearish, with the main concern being the significant potential fines and restrictions from ongoing U.S. anti-money laundering investigations, which could offset TD's operational momentum and capital markets strength. The single biggest risk flagged is the immediate and quantifiable AML settlement risk, while the key opportunity is the potential for multiple expansion and capital markets strength to drive targets, despite questions about earnings quality and sustainability.
multiple expansion and capital markets strength
AML settlement risk